» Authors » C N Williams

C N Williams

Explore the profile of C N Williams including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 102
Citations 875
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Morlighem M, Williams C, Rignot E, An L, Arndt J, Bamber J, et al.
Geophys Res Lett . 2017 Dec; 44(21):11051-11061. PMID: 29263561
Greenland's bed topography is a primary control on ice flow, grounding line migration, calving dynamics, and subglacial drainage. Moreover, fjord bathymetry regulates the penetration of warm Atlantic water (AW) that...
2.
3.
Williams C
Saudi J Gastroenterol . 2009 Oct; 7(3):122-3. PMID: 19861782
No abstract available.
4.
Williams C
Inflamm Bowel Dis . 2008 Sep; 14 Suppl 2:S41-2. PMID: 18816730
No abstract available.
5.
Daley M, Argeriou M, McCarty D, Callahan Jr J, Shepard D, Williams C
J Psychoactive Drugs . 2001 May; 33(1):57-66. PMID: 11333002
During the 1990s, substance abuse treatment programs were developed for pregnant women to help improve infant birth outcomes, reduce maternal drug dependency and promote positive lifestyle changes. This study compared...
6.
Daley M, Argeriou M, McCarty D, Callahan Jr J, Shepard D, Williams C
J Subst Abuse Treat . 2001 Feb; 19(4):445-58. PMID: 11166509
Although many pregnant, drug-dependent women report extensive criminal justice involvement, few studies have examined reductions in crime as an outcome of substance abuse treatment programs for pregnant women. This is...
7.
Schreiber S, Fedorak R, Nielsen O, Wild G, Williams C, Nikolaus S, et al.
Gastroenterology . 2000 Dec; 119(6):1461-72. PMID: 11113067
Background & Aims: Interleukin (IL)-10 is a cytokine with potent anti-inflammatory properties. We investigated the safety and efficacy of different doses of human recombinant (rhu)IL-10 in patients with Crohn's disease...
8.
Williams C, Al-Knawy B, Blanchard W
Aliment Pharmacol Ther . 2000 Sep; 14(9):1133-9. PMID: 10971229
Background: Ursodeoxycholic acid (UDCA) is the drug of choice for treating primary biliary cirrhosis and dissolving cholesterol gallstones. Objectives: The objective of this study was to compare the bioavailability of...
9.
Hanauer S, Good L, GOODMAN M, Pizinger R, Strum W, Lyss C, et al.
Am J Gastroenterol . 2000 Aug; 95(7):1749-54. PMID: 10925979
Objective: The purpose of this study was to evaluate the efficacy and safety of a single nightly 500-mg Rowasa (mesalamine) suppository as maintenance therapy for patients with ulcerative proctitis in...
10.
Rioux J, Silverberg M, Daly M, Steinhart A, McLeod R, Griffiths A, et al.
Am J Hum Genet . 2000 Apr; 66(6):1863-70. PMID: 10777714
The chronic inflammatory bowel diseases (IBDs)-Crohn disease (CD) and ulcerative colitis (UC)-are idiopathic, inflammatory disorders of the gastrointestinal tract. These conditions have a peak incidence in early adulthood and a...